Invitrogen Overview

  • Year Founded
  • 1987

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 10,400

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 7

  • Investments
  • 42

Invitrogen General Information

Description

Provider of genetic testing equipment and products intended to support biotechnological research. The company's genetic testing equipment and products include a range of differentiated reagents, kits, and benchtop devices that are easy to access and easy to buy, enabling laboratories to accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 5791 Van Allen Way
  • Carlsbad, CA 92008
  • United States
+1 (760)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 5791 Van Allen Way
  • Carlsbad, CA 92008
  • United States
+1 (760)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Invitrogen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Invitrogen‘s full profile, request access.

Request a free trial

Invitrogen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of genetic testing equipment and products intended to support biotechnological research. The company's genetic
Biotechnology
Carlsbad, CA
10,400 As of 2014

Madrid, Spain
 

Ebersberg, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Invitrogen Competitors (32)

One of Invitrogen’s 32 competitors is Condalab, a Corporation company based in Madrid, Spain.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Condalab Corporation Madrid, Spain
Eurofins Genomics Europe Shared Services Corporation Ebersberg, Germany
Editas Medicine Formerly VC-backed Cambridge, MA
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
Integrated DNA Technologies Formerly PE-Backed Coralville, IA
You’re viewing 5 of 32 competitors. Get the full list »

Invitrogen Patents

Invitrogen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202511746-D0 Coated particles Pending 18-Jul-2025
US-D1153780-S1 Polymerase chain reaction instrument Active 09-May-2025
WO-2026236250-A1 Photoacoustic imaging compounds and methods of use Pending 06-May-2025
WO-2026231630-A1 Amplification-based optical calibration for digital polymerase chain reaction (dpcr) spectroscopy Pending 30-Apr-2025
WO-2026231588-A1 Methods of making site-specific activated antibodies and antibody conjugates Pending 29-Apr-2025
To view Invitrogen’s complete patent history, request access »

Invitrogen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Invitrogen Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Invitrogen‘s full profile, request access.

Request a free trial

Invitrogen Investments & Acquisitions (42)

Invitrogen’s most recent deal was a Joint Venture with Huakang Smart Cloud. The deal was made on 01-Jun-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Huakang Smart Cloud 01-Jun-2022 Joint Venture Systems and Information Management
Claritas Genomics 18-Oct-2013 Early Stage VC Laboratory Services (Healthcare)
Life Science Korea 13-Jun-2013 Merger/Acquisition Distributors/Wholesale
KDR Biotech Company 12-Apr-2013 Merger/Acquisition Industrial Chemicals
BAC 22-Jan-2013 Merger/Acquisition Biotechnology
You’re viewing 5 of 42 investments and acquisitions. Get the full list »

Invitrogen Exits (4)

Invitrogen’s most recent exit was on 18-Oct-2013 from Claritas Genomics. The exit was categorized as with 4 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Claritas Genomics 18-Oct-2013 Completed
  • 4 buyers
SGB Biofuels 17-Jan-2012 Completed
  • 5 buyers
SGB Biofuels 14-Sep-2010 Completed
  • 2 buyers
Eurofins Genomics Blue Heron 19-Dec-2006 Later Stage VC Completed
  • 5 buyers
To view Invitrogen’s complete exits history, request access »

Invitrogen Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Life Technologies Pension Plan Carlsbad, CA 1975

Invitrogen FAQs

  • When was Invitrogen founded?

    Invitrogen was founded in 1987.

  • Where is Invitrogen headquartered?

    Invitrogen is headquartered in Carlsbad, CA.

  • What is the size of Invitrogen?

    Invitrogen has 10,400 total employees.

  • What industry is Invitrogen in?

    Invitrogen’s primary industry is Biotechnology.

  • Is Invitrogen a private or public company?

    Invitrogen is a Private company.

  • What is the current valuation of Invitrogen?

    The current valuation of Invitrogen is .

  • What is Invitrogen’s current revenue?

    The current revenue for Invitrogen is .

  • How much funding has Invitrogen raised over time?

    Invitrogen has raised $5B.

  • Who are Invitrogen’s investors?

    New Enterprise Associates and TA Associates Management have invested in Invitrogen.

  • Who are Invitrogen’s competitors?

    Condalab, Eurofins Genomics Europe Shared Services, Editas Medicine, Adaptimmune Therapeutics, and Integrated DNA Technologies are some of the 32 competitors of Invitrogen.

  • When was Invitrogen acquired?

    Invitrogen was acquired on 04-Feb-2014.

  • Who acquired Invitrogen?

    Invitrogen was acquired by Thermo Fisher Scientific.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process